NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 09/04/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization22,063 mln
Float129 mln
Earnings Date10/29/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.84
Likely reliable
1-Year Forecast
194
Attractive
Relative Strength
18
/ 100
Significantly lagging
Debt / Equity
-7.61
Negative equity
Pre-Tax Margin
-38%
Deeply loss-making
Business Description
Guardant Health is a cancer diagnostics company founded in 2011 and based in Palo Alto, California, that develops blood and tissue tests to detect and analyze cancer. Its products help doctors identify genetic changes in tumors, guiding treatment decisions for patients, and also include a blood test designed to screen healthy adults for colorectal cancer. The company additionally supports pharmaceutical research by offering data, software tools, and services that help connect patients with relevant clinical trials and advance the development of new cancer therapies.
